A similar analysis of CEAIn expression and EGFR mutation status in adenocarcinoma patients (n = 517) revealed that serum CEAIn levels were higher in the EGFR-mutant than in the wild-type group (Supplementary Fig. 1B). The gene discussed is EGFR; the disease is adenocarcinoma.